Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-29 Sale |
2025-01-30 12:15 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
546 | $29.52 | $16,120 | 199,061 (Indirect Direct) |
View |
| 2025-01-22 Sale |
2025-01-23 3:37 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
3,088 | $30.43 | $93,954 | 199,607 (Indirect Direct) |
View |
| 2025-01-17 Sale |
2025-01-21 4:11 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
1,730 | $29.96 | $51,828 | 202,695 (Indirect Direct) |
View |
| 2025-01-13 Sale |
2025-01-14 4:25 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
2,170 | $28.7 | $62,284 | 158,496 (Indirect Direct) |
View |
| 2024-04-01 Sale |
2024-04-02 4:06 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
4,000 | $58.66 | $234,640 | 407,473 (Indirect Direct) |
View |
| 2024-03-01 Sale |
2024-03-05 4:04 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
6,000 | $63.22 | $379,340 | 411,473 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:59 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
1,431 | $67.77 | $96,974 | 149,570 (Indirect Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 4:34 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
906 | $64.14 | $58,109 | 151,001 (Indirect Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 6:13 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
3,551 | $65 | $230,801 | 151,907 (Indirect Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:36 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
2,235 | $66.81 | $149,317 | 189,991 (Indirect Direct) |
View |
| 2023-11-30 Sale |
2023-12-01 4:11 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
14,158 | $54.73 | $774,884 | 401,848 (Indirect Direct) |
View |
| 2023-07-03 Sale |
2023-07-06 4:16 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
6,779 | $89.97 | $609,928 | 416,006 (Indirect Direct) |
View |
| 2023-06-05 Sale |
2023-06-06 4:59 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
69,779 | $88.8 | $6,196,527 | 422,785 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-21 Option Award |
2025-01-21 4:11 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
45,929 | $0 | 202,695 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 4:09 pm |
N/A 2028-02-15 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
11,096 | $0 | 269,570 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 4:09 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
10,054 | $13.85 | 269,570 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 4:09 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
1,042 | $14.95 | 269,570 (Direct) |
View |
| 2024-04-18 Gift |
2024-04-19 7:27 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
14,164 | $0 | 149,570 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-02 4:06 pm |
N/A 2027-10-18 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
4,000 | $0 | 407,473 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-02 4:06 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
4,000 | $10.03 | 407,473 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:04 pm |
N/A 2027-10-18 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
6,000 | $0 | 411,473 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:04 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
6,000 | $10.03 | 411,473 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:36 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
34,533 | $66.3 | 189,991 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:36 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
23,748 | $0 | 189,991 (Direct) |
View |
| 2023-11-30 Exercise |
2023-12-01 4:11 pm |
N/A 2027-10-18 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
14,158 | $0 | 401,848 (Direct) |
View |
| 2023-11-30 Exercise |
2023-12-01 4:11 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
14,158 | $10.03 | 401,848 (Direct) |
View |
| 2023-07-03 Exercise |
2023-07-06 4:16 pm |
N/A 2027-10-18 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
6,779 | $0 | 416,006 (Direct) |
View |
| 2023-07-03 Exercise |
2023-07-06 4:16 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
6,779 | $10.03 | 416,006 (Direct) |
View |
| 2023-06-05 Exercise |
2023-06-06 4:59 pm |
N/A 2027-10-18 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
69,779 | $0 | 422,785 (Direct) |
View |
| 2023-06-05 Exercise |
2023-06-06 4:59 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
69,779 | $10.03 | 422,785 (Direct) |
View |
| 2023-05-03 Gift |
2023-05-03 4:22 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
20,000 | $0 | 133,945 (Direct) |
View |
| 2023-04-19 Gift |
2023-04-20 4:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
36,232 | $0 | 133,945 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-22 06:42 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
28,255 | $0 | 150,517 (Direct) |
View |
| 2023-02-21 Tax Withholding |
2023-02-22 06:42 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
974 | $58.5 | 150,517 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 4:59 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
975 | $51.21 | 123,236 (Direct) |
View |
| 2023-01-27 Tax Withholding |
2023-01-30 5:05 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
551 | $52.77 | 124,211 (Direct) |
View |
| 2023-01-20 Tax Withholding |
2023-01-24 5:23 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
2,379 | $52.05 | 124,762 (Direct) |
View |
| 2022-04-25 Other |
2023-01-17 8:00 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
26,250 | $0 | 174,074 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 8:00 pm |
N/A 2033-01-11 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
43,183 | $52.66 | 174,074 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 8:00 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
27,488 | $0 | 174,074 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:17 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
875 | $47.12 | 103,403 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:05 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
650 | $38.59 | 104,278 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:57 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
74,457 | $0 | 148,598 (Direct) |
View |
| 2021-06-08 Exercise |
2021-06-09 4:06 pm |
N/A 2027-10-19 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
39,880 | $0 | 432,760 (Direct) |
View |
| 2021-06-08 Exercise |
2021-06-09 4:06 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
39,880 | $10.03 | 432,760 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-11 4:16 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
858 | $47.72 | 34,261 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 4:42 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
78,750 | $0 | 102,619 (Direct) |
View |